Skip to main content

What the FDA labels say about taking them together

Apixaban and phenytoin

Apixaban's FDA label of April 24, 2026 names phenytoin in its drug interactions section, and phenytoin's label names apixaban too. The apixaban label: “Avoid concomitant use of ELIQUIS with combined P-gp and strong CYP3A4 inducers because such drugs will decrease exposure to apixaban.”

Check it at the source: the apixaban FDA label on DailyMed (effective April 24, 2026, Cardinal Health 107, LLC); the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.).

What does the apixaban label say about phenytoin?

Apixaban label, drug interactions

Avoid concomitant use of ELIQUIS with combined P-gp and strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) because such drugs will decrease exposure to apixaban [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (ELIQUIS), NDA202155 (Bristol Myers Squibb), as published by Cardinal Health 107, LLC, effective April 24, 2026 (SPL set a454cd24-0c6d-46e8-b1e4-197388606175), via openFDA; the full label on DailyMed

What does the phenytoin label say about apixaban?

Phenytoin label, drug interactions

Interacting Agent: Anticoagulants; Examples: Apixaban, dabigatran, edoxaban, rivaroxaban

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Apixaban generic labelers
29Phenytoin generic labelers
ApixabanPhenytoin
Labeled forAtrial fibrillation, Blood clots (DVT and PE), Stroke preventionSeizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)$5.52 per tablet 5 mg tablet$0.145 per capsule 100 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?